| RS372931505 |
CEBPA
|
Health Risk |
Conflicting classifications of pathogenicity |
Acute myeloid leukemia, Hereditary cancer-predisposing syndrome |
| RS372931895 |
STRA6
|
Health Risk |
Pathogenic |
Anophthalmia-microphthalmia syndrome, Anophthalmia-microphthalmia syndrome |
| RS372932575 |
SLC24A5
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS372933126 |
HGSNAT
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosis, MPS-III-C |
| RS372933587 |
MYO18B
|
Health Risk |
Conflicting classifications of pathogenicity |
See cases, Inborn genetic diseases |
| RS372934565 |
CDH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary diffuse gastric adenocarcinoma, Hereditary cancer-predisposing syndrome |
| RS372935423 |
ARSL
|
Health Risk |
Conflicting classifications of pathogenicity |
Chondrodysplasia punctata, brachytelephalangic |
| RS372935580 |
PIEZO1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS372935996 |
SZT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Developmental and epileptic encephalopathy |
| RS372937480 |
ARSA
|
Health Risk |
Conflicting classifications of pathogenicity |
Metachromatic leukodystrophy, Inborn genetic diseases |
| RS372938259 |
SPTBN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Spinocerebellar ataxia type 5, Autosomal recessive spinocerebellar ataxia 14 |
| RS372938477 |
LRP2
|
Health Risk |
Pathogenic/Likely pathogenic |
Donnai-Barrow syndrome, Donnai-Barrow syndrome |
| RS372939044 |
MYO18B
|
Health Risk |
Pathogenic |
— |
| RS372939605 |
GPAA1
|
Health Risk |
Pathogenic/Likely pathogenic |
GPAA1-related disorder, GPAA1-related disorder |
| RS372939622 |
CHIT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Chitotriosidase deficiency, Chitotriosidase deficiency |
| RS372939761 |
BBS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Bardet-Biedl syndrome, Bardet-Biedl syndrome 1 |
| RS372939794 |
MYLK
|
Health Risk |
Conflicting classifications of pathogenicity |
Aortic aneurysm, familial thoracic 7 |
| RS372939905 |
POMT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2 |
| RS372940610 |
FLNB
|
Health Risk |
Likely pathogenic |
Larsen syndrome, Larsen syndrome |
| RS372940792 |
SNRNP200
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS372940918 |
EPG5
|
Health Risk |
Pathogenic/Likely pathogenic |
Vici syndrome, Vici syndrome |
| RS372941705 |
POR
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency, Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency |
| RS372941709 |
COL11A1
|
Health Risk |
Conflicting classifications of pathogenicity |
COL11A1-related disorder, COL11A1-related disorder |
| RS372942015 |
PKD1L3
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS372942165 |
KCNV2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cone dystrophy with supernormal rod response, Cone dystrophy with supernormal rod response |
| RS372942259 |
PLEC
|
Health Risk |
Conflicting classifications of pathogenicity |
Epidermolysis bullosa simplex 5C, with pyloric atresia |
| RS372943622 |
CDK13
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS372945746 |
SMCHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Facioscapulohumeral muscular dystrophy 2, Facioscapulohumeral muscular dystrophy 2 |
| RS372946484 |
ADGRA3
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS372946517 |
PDE4D
|
Health Risk |
Conflicting classifications of pathogenicity |
Acrodysostosis 2 with or without hormone resistance, PDE4D-related disorder |
| RS372946560 |
NTHL1
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial adenomatous polyposis 3, Hereditary cancer-predisposing syndrome |
| RS372947059 |
CALM2
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome 1, Cardiovascular phenotype |
| RS372947070 |
CELA2A
|
Health Risk |
Pathogenic |
Coronary artery disorder, Hypertriglyceridemia |
| RS372947142 |
NPC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Niemann-Pick disease, type C1 |
| RS372947820 |
ASCC3
|
Health Risk |
Pathogenic |
Intellectual developmental disorder, autosomal recessive 81 |
| RS372948989 |
EGFR
|
Health Risk |
Conflicting classifications of pathogenicity |
EGFR-related lung cancer, Inflammatory skin and bowel disease |
| RS372949000 |
LRBA
|
Health Risk |
Conflicting classifications of pathogenicity |
Combined immunodeficiency due to LRBA deficiency, LRBA-related disorder |
| RS372949028 |
TANGO2
|
Health Risk |
Pathogenic |
Intellectual disability, Acute rhabdomyolysis |
| RS372949456 |
VPS13B
|
Health Risk |
Pathogenic |
— |
| RS372949783 |
PEPD
|
Health Risk |
Conflicting classifications of pathogenicity |
Prolidase deficiency, Prolidase deficiency |
| RS372950672 |
SBF1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS372950890 |
SKI
|
Health Risk |
Conflicting classifications of pathogenicity |
Shprintzen-Goldberg syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS372952479 |
DCHS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS372953205 |
RHBDF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Palmoplantar keratoderma-esophageal carcinoma syndrome, Inborn genetic diseases |
| RS372953250 |
COQ8A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS372953477 |
ADAMTS13
|
Health Risk |
Conflicting classifications of pathogenicity |
Upshaw-Schulman syndrome, Upshaw-Schulman syndrome |
| RS372953537 |
PDE3A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, PDE3A-related disorder |
| RS372953726 |
KMT2B
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS372954109 |
ARHGEF10
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS372955218 |
KPTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Macrocephaly-developmental delay syndrome, Inborn genetic diseases |
| RS372955658 |
TTC12
|
Health Risk |
Pathogenic |
Ciliary dyskinesia, primary |
| RS372956200 |
LAMA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Muscular dystrophy, limb-girdle |
| RS372956932 |
SCNN1A
|
Health Risk |
Pathogenic |
Bronchiectasis with or without elevated sweat chloride 2, Liddle syndrome 3 |
| RS372959912 |
LRRC56
|
Health Risk |
Pathogenic |
Ciliary dyskinesia, primary |
| RS372960797 |
MAPKAPK3
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS372963310 |
VLDLR
|
Health Risk |
Conflicting classifications of pathogenicity |
Cerebellar ataxia, intellectual disability |
| RS372963343 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Cardiomyopathy |
| RS372963832 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS372963982 |
COL11A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Stickler syndrome type 2, Fibrochondrogenesis 1 |
| RS372964069 |
DYNC2H1
|
Health Risk |
Conflicting classifications of pathogenicity |
Jeune thoracic dystrophy, Jeune thoracic dystrophy |
| RS372964579 |
CPA6
|
Health Risk |
Conflicting classifications of pathogenicity |
Febrile seizures, familial |
| RS3729659 |
ACE
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal tubular dysgenesis, Renal tubular dysgenesis |
| RS3729660 |
ACE
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal tubular dysgenesis, Renal tubular dysgenesis |
| RS372966682 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS372966951 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS372966991 |
GLA;HNRNPH2;RPL36A-HNRNPH2
|
Health Risk |
Pathogenic/Likely pathogenic |
Fabry disease, Cardiovascular phenotype |
| RS372967537 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Catecholaminergic polymorphic ventricular tachycardia, Cardiovascular phenotype |
| RS372967646 |
DICER1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, DICER1-related tumor predisposition |
| RS372968576 |
C8B
|
Health Risk |
Pathogenic |
Type II complement component 8 deficiency, Type II complement component 8 deficiency |
| RS372968732 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS372969054 |
NHS
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Nance-Horan syndrome |
| RS372970620 |
GRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Fraser syndrome 3, Fraser syndrome 3 |
| RS372970635 |
APC
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, APC-Associated Polyposis Disorders |
| RS372970828 |
SCN5A
|
Health Risk |
Conflicting classifications of pathogenicity |
Brugada syndrome 1, Sick sinus syndrome 1 |
| RS372970842 |
BAG3
|
Health Risk |
Conflicting classifications of pathogenicity |
Myofibrillar myopathy 6, Dilated cardiomyopathy 1HH |
| RS3729711 |
TNNI3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Hypertrophic cardiomyopathy |
| RS3729712 |
TNNI3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Hypertrophic cardiomyopathy |
| RS372971566 |
COL5A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Ehlers-Danlos syndrome |
| RS372971671 |
EPHB4
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS3729732 |
LIFR
|
Health Risk |
Conflicting classifications of pathogenicity |
Stüve-Wiedemann syndrome 1, Stüve-Wiedemann syndrome 1 |
| RS372973682 |
ZNF469
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS372974399 |
DNAH5
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS372974717 |
EBP
|
Health Risk |
Pathogenic/Likely pathogenic |
Chondrodysplasia punctata 2 X-linked dominant, Chondrodysplasia punctata 2 X-linked dominant |
| RS3729751 |
LIFR
|
Health Risk |
Conflicting classifications of pathogenicity |
Stuve-Wiedemann syndrome, Congenital anomaly of kidney and urinary tract |
| RS3729754 |
NKX2-5
|
Health Risk |
Conflicting classifications of pathogenicity |
Atrial septal defect 7, Cardiovascular phenotype |
| RS372976742 |
ABCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
ABCA4-related disorder, Retinitis pigmentosa |
| RS372977009 |
SKIC2
|
Health Risk |
Pathogenic |
— |
| RS372979075 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS372979339 |
ATP7B
|
Health Risk |
Conflicting classifications of pathogenicity |
Wilson disease, ATP7B-related disorder |
| RS372980573 |
FAH
|
Health Risk |
Conflicting classifications of pathogenicity |
Tyrosinemia type I, Tyrosinemia type I |
| RS372980930 |
ANLN
|
Health Risk |
Conflicting classifications of pathogenicity |
Focal segmental glomerulosclerosis 8, ANLN-related disorder |
| RS372981030 |
SPG7
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spastic paraplegia 7, Hereditary spastic paraplegia |
| RS372981316 |
LTBP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Glaucoma 3, primary congenital |
| RS372982681 |
KMT2B
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS3729831 |
MYH7
|
Health Risk |
Conflicting classifications of pathogenicity |
MYH7-related skeletal myopathy, Hypertrophic cardiomyopathy |
| RS372983141 |
GCDH
|
Health Risk |
Pathogenic/Likely pathogenic |
Glutaric aciduria, type 1 |
| RS372983350 |
TNXB
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS3729841 |
TNNI3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Hypertrophic cardiomyopathy |
| RS372984423 |
LMNB1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS372984801 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |